4Moving Biotech Closes Euros 12M Financing for Knee OA Program
4Moving Biotech (4MB), a clinical-stage biotechnology company and a spin-off of 4P-Pharma, developing a first-in-class disease-modifying osteoarthritis drug (DMOAD) for knee osteoarthritis, announced on February 10th the closing of a €12 million financing, completed through a structured and coordinated funding process. This financing was secured from a pool of private investors and family offices, who […]
How Digital Surveillance Tools Are Transforming Healthcare Fraud Prevention
Healthcare fraud doesn’t look like what you think it does. It’s not just shady clinics billing for services never rendered or stolen patient IDs floating around the dark web. It’s deeper. More subtle. And often, it hides behind what looks like routine prescription activity. That’s the real issue—the fraud doesn’t announce itself. It shows up […]
Feinstein Institutes Researchers Demonstrate Successful Study of Lupus Kidney Disease
Researchers at Northwell Health’s Feinstein Institutes for Medical Research found that obinutuzumab, a therapeutic antibody that depletes B cells and is approved for the treatment of B cell malignancies, benefitted patients with lupus nephritis, a severe complication of lupus that compromises kidney function. The study, which was led by Richard A. Furie, MD, professor in the Feinstein Institutes’ Institute of […]
Merck Signs MoU with KAIST to Further Scientific Partnership in South Korea
Merck, a leading science and technology company, has signed a non-binding Memorandum of Understanding (MoU) with the Korea Advanced Institute of Science and Technology (KAIST). The academia-industry cooperation aims to advance the research and development ecosystem in South Korea for industrial applications. “Our collaboration with KAIST is an important step towards accelerating the biotechnology ramp-up […]
